LivaNova PLC Ordinary Shares (LIVN)
Health Care – ELECTROMEDICAL & ELECTROTHERAPEUTIC APPARATUS
- Headquarters
- United States
- Employees
- 3,300
- Market Cap
- $4.2B
About LivaNova PLC Ordinary Shares
UK-based LivaNova was born of a combination of Cyberonics in the US and Sorin in Italy. The medical-device firm is primarily focused on cardiopulmonary solutions (with heart-lung machines and oxygenation equipment) as well as neuromodulation devices for treatment-resistant epilepsy and depression. Following the merger, LivaNova divested its cardiac rhythm management, heart valve, and extracorporeal membrane oxygenation businesses. It derives approximately half of its revenue from the US market, another 21% from Europe, and the remainder from the rest of the world.
SentiSense also tracks daily options readings for LivaNova PLC Ordinary Shares: IV rank, put/call percentile, 25-delta skew, open-interest walls, and unusually active contracts, each measured against the stock's own history. Sign in to view them.
LivaNova PLC Ordinary Shares stock analysis, sentiment tracking, and market intelligence on SentiSense.